Antivirals against monkeypox infections

Kevin Chiem(Texas Biomedical Research Institute), Luis Martínez‐Sobrido(Texas Biomedical Research Institute)

bioRxiv (Cold Spring Harbor Laboratory)

April 19, 2023

10.1101/2023.04.19.537483

Cited by 4

Related Papers

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

|Nature|2020|856

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

|The Lancet Microbe|2021|435

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

|bioRxiv (Cold Spring Harbor Laboratory)|2020|113

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene

|mBio|2020|48

Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera

|Nature Communications|2022|41